Contact Us
Drug Search Results
More Filters [+]

Piribedil

Alternative Names: piribedil
Latest Update: 2024-04-26
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: D2 Agonist,D3 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Brazil | Bulgaria | Chile | Egypt | France | Germany | Greece | India | Ireland | Italy | Jordan | Latvia | Lithuania | Luxembourg | Malaysia | Malta | Morocco | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Singapore | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Desitin Arzneimittel
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Piribedil

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Parkinson's Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PIR-008/K

N/A

Completed

Parkinson's Disease

2014-12-01

PIVICOG-PD

P3

Completed

Parkinson's Disease

2011-12-07

PIVICOG-PD

P3

Completed

Parkinson's Disease

2011-12-01

PIR-002/K

N/A

Completed

Parkinson's Disease

2008-12-01

Recent News Events

Date

Type

Title

04/26/2024

PubMed

 A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models.

02/05/2024

PubMed

 Delusional Infestation in Parkinson's Disease Secondary to Piribedil Escalation: An Uncommon Case Report.

01/01/2024

PubMed

 [Tremor-dominant form of Parkinson's disease].

08/30/2023

News Article

 Parkinson Treatment Drug Market 2023 Advancement and Growth Outlook -Merck, Akorn, GSK

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions